Evidence map›Paper›PMID 42667392›Full record

ArticlePsychopharmacology2026

C57BL/6N mutation in cytoplasmic FMRP interacting protein 2 regulates nicotine reward in the conditioned place preference test.

Belle Buzzi, Gina M Fernandez, Amber Baldwin, Alayna Palamar, Belinda Cornes, Vivek Kumar, M Imad Damaj

Abstract read
PubMed Publisher
In one paragraph

Article in Psychopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Belle BuzziDepartment of Pharmacology and Toxicology, and Translational Research Initiative for Pain and Neuropathy, Virginia Commonwealth University, 1217 East Marshall Street Richmond, Richmond, VA, 23298, USA.
Gina M FernandezDepartment of Psychology, Christopher Newport University, 1 Avenue of the Arts, Newport News, VA, 23606, USA.
Amber BaldwinNeuroscience Program, Christopher Newport University, 1 Avenue of the Arts, Newport News, VA, 23606, USA.
Alayna PalamarDepartment of Pharmacology and Toxicology, and Translational Research Initiative for Pain and Neuropathy, Virginia Commonwealth University, 1217 East Marshall Street Richmond, Richmond, VA, 23298, USA.
Belinda CornesThe Jackson Laboratory, Bar Harbor, ME, USA.
Vivek KumarThe Jackson Laboratory, Bar Harbor, ME, USA.
M Imad DamajDepartment of Pharmacology and Toxicology, and Translational Research Initiative for Pain and Neuropathy, Virginia Commonwealth University, 1217 East Marshall Street Richmond, Richmond, VA, 23298, USA. m.damaj@vcuhealth.org.

Funding

Genetic basis of nicotine withdrawal in a reduced complexity crossU01DA045299 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI DAMAJ, M. IMAD, KUMAR, VIVEK · 2018 to 2022
$2.7M
NIDA NIH HHS U01 DA045299
6 · The paper itself

Abstract

Tobacco use is the leading preventable cause of death in the United States. Among the factors that contribute to tobacco initiation, use, and dependence, genetics may exert a strong influence. In mouse models, genetic differences between strains have been studied to investigate the potential drivers for these states. Previous reports indicate that C57BL/6 J (B6J) and C57BL/6N (B6N) mouse substrains show varying behavioral responses towards both natural and drug rewards. However, nicotine reward as assessed by preference for nicotine in the conditioned place preference (CPP) test has not yet been evaluated. Additionally, a point mutation in the cytoplasmic FMRP interacting protein 2 (Cyfip2) gene has been regarded as a potential underlying factor towards these substrain differences. Here, we compare the response to nicotine between B6J and B6N mouse substrains and establish a genetic correlation between Cyfip2 expression and nicotine preference in the brain. We also examine the effects of this mutation on nicotine preference between these substrains. We report reduced preference for nicotine in B6N mice compared to B6J mice and a negative correlation between nicotine CPP scores and Cyfip2 expression in both the hippocampus and prefrontal cortex. In our investigation of the Cyfip2 variant, we found that B6J mice carrying the B6N Cyfip2 mutation showed a lower preference for nicotine while B6N mice carrying the B6J Cyfip2 mutation showed increased preference. This study establishes substrain differences in preference for nicotine in the CPP test and a mutation in the Cyfip2 as the causal variant for this behavior.

Indexed as

C57BL/6 substrainsConditioned place preferenceMiceNicotine

Identifiers

PMID42667392

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.